A detailed history of Slate Stone Wealth, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 8,458 shares of TMDX stock, worth $684,505. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,458
Previous 5,681 48.88%
Holding current value
$684,505
Previous $856,000 55.14%
% of portfolio
0.12%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$135.68 - $176.11 $376,783 - $489,057
2,777 Added 48.88%
8,458 $1.33 Million
Q2 2024

Jul 25, 2024

BUY
$72.62 - $150.62 $412,554 - $855,672
5,681 New
5,681 $856,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Slate Stone Wealth, LLC Portfolio

Follow Slate Stone Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.